Skip to main navigation Skip to search Skip to main content

Helicobacter pylori Eradication Therapy for Colorectal Mucosa-associated Lymphoid Tissue Lymphoma: Report of Two Cases

  • Erika Teramura
  • , Ryuzo Deguchi
  • , Takashi Ueda
  • , Masashi Morimachi
  • , Masaya Sano
  • , Hirohiko Sato
  • , Mia Fujisawa
  • , Kota Tsuruya
  • , Yoshitaka Arase
  • , Tatehiro Kagawa

Research output: Contribution to journal › Article › peer-review

Abstract

Two cases of colorectal mucosa-associated lymphoid tissue lymphoma (cMALT) are presented and discussed with the reports from 1997 to the present. Helicobacter pylori (HP)-negative cases showed tumor resolution 2 months after eradication therapy. HP-positive cases were successfully eradicated and tumor resolution was confirmed 16 months later. Analysis of the data reported to date shows that cMALT resolution rates were 68.4% (13/19) in the HP-negative group and 33.3% (7/21) in the HP-positive group. HP eradication should be considered the primary treatment for cMALT regardless of HP infection, especially in untreated patients under follow-up.

Original languageEnglish
Pages (from-to)122-127
Number of pages6
JournalTokai Journal of Experimental and Clinical Medicine
Volume49
Issue number3
Publication statusPublished - 09-2024
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • General Medicine

Fingerprint

Dive into the research topics of 'Helicobacter pylori Eradication Therapy for Colorectal Mucosa-associated Lymphoid Tissue Lymphoma: Report of Two Cases'. Together they form a unique fingerprint.

Cite this